BRAINBox Solutions, Inc. Email Format
Biotechnology ResearchVirginia, United States11-50 Employees
BRAINBox Solutions, Inc. operates in biotechnology research with a focus on traumatic brain injury diagnostics and prognostics. It uses a combination of blood biomarker panels accessible on point-of-care devices and standard lab systems, together with neurocognitive testing, to establish objective evidence of injury and to estimate likely recovery. The company is based in Richmond, Virginia, and operates as a smaller enterprise. In 2026, the company reported progress on its BRAINBox TBI diagnostic and prognostic test program. It has pursued collaborations and partnerships, including a March 2026 collaboration with Prolight Diagnostics and a 2025 integration with Oragenics, and it has a history of collaboration with the University of Pennsylvania dating back to 2022. In May 2026, the company appointed Richard H. Noel as Chief Product and Commercial Officer.